ACR Defends Mammographic Exams For Women 35-40,Says Carcinogenic Threat Is “Small”
In Brief: Hazleton Acquires Prime Labs, Primate Importer; Cullen UCLA Deputy Director
House Committee Expands Rauscher Pay Bill, Includes All NIH Directors, Asst. Secretary
Conferees Agree On $815 Million For NCI In ‘77
ACS-Roosevelt Awards Go to 19 New Fellows
Tobacco Council Lists 14 Smoking-Health Awards
Litton’s New Fredrick Award Could Total Around $30 Million
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- FDA’s OCE publishes three final guidances to increase clinical trial enrollment
